These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10969206)

  • 1. [14-3-3sigma (stratifin), a potential tumor suppressor frequently inactivated by methylation in cancer of the breast].
    Jeanteur P
    Bull Cancer; 2000 Jul; 87(7-8):525. PubMed ID: 10969206
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
    Lodygin D; Hermeking H
    Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
    Umbricht CB; Evron E; Gabrielson E; Ferguson A; Marks J; Sukumar S
    Oncogene; 2001 Jun; 20(26):3348-53. PubMed ID: 11423985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.
    Osada H; Tatematsu Y; Yatabe Y; Nakagawa T; Konishi H; Harano T; Tezel E; Takada M; Takahashi T
    Oncogene; 2002 Apr; 21(15):2418-24. PubMed ID: 11948426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.
    Gasco M; Sullivan A; Repellin C; Brooks L; Farrell PJ; Tidy JA; Dunne B; Gusterson B; Evans DJ; Crook T
    Oncogene; 2002 Mar; 21(12):1876-81. PubMed ID: 11896620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of 14-3-3sigma in cancer.
    Lodygin D; Hermeking H
    Semin Cancer Biol; 2006 Jun; 16(3):214-24. PubMed ID: 16698281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.
    Gasco M; Bell AK; Heath V; Sullivan A; Smith P; Hiller L; Yulug I; Numico G; Merlano M; Farrell PJ; Tavassoli M; Gusterson B; Crook T
    Cancer Res; 2002 Apr; 62(7):2072-6. PubMed ID: 11929827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
    Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
    Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor suppressor gene 14-3-3 sigma is commonly methylated in normal and malignant lymphoid cells.
    Bhatia K; Siraj AK; Hussain A; Bu R; Gutiérrez MI
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):165-9. PubMed ID: 12582028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
    Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
    Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
    Lodygin D; Diebold J; Hermeking H
    Oncogene; 2004 Dec; 23(56):9034-41. PubMed ID: 15489902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
    Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.
    Conway KE; McConnell BB; Bowring CE; Donald CD; Warren ST; Vertino PM
    Cancer Res; 2000 Nov; 60(22):6236-42. PubMed ID: 11103776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.
    Vercoutter-Edouart AS; Lemoine J; Le Bourhis X; Louis H; Boilly B; Nurcombe V; Révillion F; Peyrat JP; Hondermarck H
    Cancer Res; 2001 Jan; 61(1):76-80. PubMed ID: 11196201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
    Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
    Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation patterns of the CDH1, RARB, and SFN genes in choroid plexus tumors.
    Losi-Guembarovski R; Kuasne H; Guembarovski AL; Rainho CA; Cólus IM
    Cancer Genet Cytogenet; 2007 Dec; 179(2):140-5. PubMed ID: 18036402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein.
    Tobias ES; Hurlstone AF; MacKenzie E; McFarlane R; Black DM
    Oncogene; 2001 May; 20(22):2844-53. PubMed ID: 11420696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.